Scarica l'app Stockscreener
101.88
2.03%
-2.11
Pre-mercato:
102.47
0.59
+0.58%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
Abbott (ABT) Enhances Cancer Care with OncoEMR Test Integration - GuruFocus
Abbott (ABT) Dips More Than Broader Market: What You Should Know - Yahoo Finance Australia
Dairy industry consolidation | Lactalis, Abbott Complete Major NZ Dairy Deals - en.edairynews.com
SCHD ETF Rebalance Adds Abbott, UnitedHealth as Dividend Fund Inflows Hit 4-Year High - TechStock²
Abbott, Flatiron Health Integrate Precision Oncology Tests Into Oncology EMR Platform - Clinical Lab Products
Abbott Laboratories stock hits 52-week low at 102.39 USD - Investing.com
Abbott Laboratories stock hits 52-week low at 102.39 USD By Investing.com - Investing.com Australia
Abbott integrates cancer tests into Flatiron’s EMR platform By Investing.com - Investing.com India
Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform - marketscreener.com
4,700 cancer providers can now order Abbott tests in their records system - Stock Titan
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks - The Motley Fool
Inside the high-stakes business battle over feeding preterm babies - USA Today
Is Abbott Laboratories (ABT) Offering Value After Recent Share Price Weakness? - simplywall.st
Chesley Taft & Associates LLC Has $30.29 Million Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Net Worth Advisory Group Acquires Shares of 10,905 Abbott Laboratories $ABT - MarketBeat
Abbott subsidiary dodges whistleblower claim from fired remote worker - hcamag.com
Abbott Culture Alignment Supports Long Term Execution And Valuation Story - simplywall.st
Abbott Laboratories (ABT) announces completion of acquisition of Exact Sciences - MSN
Abbott Laboratories Faces Weak Start with Gap Down Amid Market Concerns - marketsmojo.com
Abbott Labs Eludes Kentucky State-Law Claims in Heart Valve Suit - Bloomberg Law News
Clinical Nutrition for Diabetes Care Market Report 2026-2030 Featuring Profiles of Key PlayersPfizer, Bayer, Sanofi-Aventis, Abbott Labs, Roche and More - GlobeNewswire
Abbott Laboratories Revenue Breakdown – BSESOF:ABL - TradingView
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), Merck & Company (MRK) and Abbott Laboratories (ABT) - The Globe and Mail
Abbott Laboratories $ABT Shares Acquired by Dakota Wealth Management - MarketBeat
Abbott Unit Beats Ex-Worker's Whistleblower Suit At 8th Circ. - Law360
Vanguard disaggregates holdings; ABT shows 0 shares (ABT) - Stock Titan
Abbott Labs Worker’s Wrongful Termination Suit Fails on Appeal - Bloomberg Law News
What Abbott Laboratories (ABT)'s Cancer Screening Deal and Libre Data Reveal About Its Chronic Care Ambitions - simplywall.st
Abbott Laboratories (ABT) Announces Completion of Acquisition of Exact Sciences - Yahoo Finance
NEC Baby Formula Lawsuit & Settlement | March 2026 Update - lawsuit-information-center.com
Abbott Laboratories (ABT) Stock Price, Trades & News - GuruFocus
Abbott hosts conference call for first-quarter earnings - Abbott MediaRoom
Abbott will report first-quarter results before markets open April 16 - Stock Titan
Abbott Laboratories stock faces pipeline scrutiny amid diagnostics slowdown in Q1 2026 - AD HOC NEWS
Abbott (NYSE: ABT) SVP receives 13,255-share restricted stock award - Stock Titan
[Form 3] ABBOTT LABORATORIES Initial Statement of Beneficial Ownership - Stock Titan
Mom Tying Abbott Formula To Baby's NEC Takes The Stand - Law360
Why Abbott (ABT) Is Betting $23B on Cancer Screening - MarketWise
Abbott Earnings Preview: What to Expect - Barchart.com
Pensionfund Sabic Takes Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories Stock Hits Day Low of $105.40 Amid Price Pressure - Markets Mojo
Abbott Laboratories Hits New 52-Week Low at USD 104.11 - Markets Mojo
Abbott Laboratories stock faces pressure amid diagnostics slowdown and FreeStyle Libre competition i - AD HOC NEWS
List of 29 Acquisitions by Abbott (Mar 2026) - Tracxn
Is It Time To Reconsider Abbott Laboratories (ABT) After Recent Share Price Weakness? - Yahoo Finance
Abbott Proclaim SCS Lawsuit Alleges Stimulator Lead Migration Resulted in Multiple Surgeries - AboutLawsuits.com
Abbott (ABT) Finalizes $21 Billion Exact Sciences (EXAS) Takeover - Blockonomi
Abbott (ABT) Stock Completes $21B Exact Sciences (EXAS) Acquisition - CoinCentral
Top Analyst Reports for Eli Lilly, RTX & Abbott - Yahoo Finance
Abbott Completes $21B Exact Sciences Deal To Expand Cancer Diagnostics - Citeline News & Insights
The Zacks Analyst Blog Highlights Eli Lilly, RTX, Abbott Laboratories, Ohio Valley Banc and Rave Restaurant - Yahoo Finance
Abbott (ABT) Stock Rated Buy on Strong Diabetes Trial Results - Insider Monkey
Abbott closes $23 billion deal to buy Madison-based Exact Sciences - Milwaukee Journal Sentinel
SG Americas Securities LLC Sells 102,478 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Labs completes acquisition of Madison’s Exact Sciences for $23 billion - Wisconsin State Journal
Marshall Financial Group LLC Sells 11,935 Shares of Abbott Laboratories $ABT - MarketBeat
Nordea Investment Management AB Has $73.97 Million Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories raised prices, prompting sales slump - MSN
E. Ohman J or Asset Management AB Invests $7.72 Million in Abbott Laboratories $ABT - MarketBeat
Dynamic Advisor Solutions LLC Sells 15,282 Shares of Abbott Laboratories $ABT - MarketBeat
Avanza Fonder AB Boosts Stock Position in Abbott Laboratories $ABT - MarketBeat
Assenagon Asset Management S.A. Increases Position in Abbott Laboratories $ABT - MarketBeat
U.S. Medical Nutrition Market Is Going to Boom | Abbott Laboratories • Nestlé Health Science • Danone - openPR.com
Abbott Laboratories (ABT) Completes Acquisition of Exact Sciences - GuruFocus
Abbott Laboratories stock completes $21 billion Exact Sciences acquisition, eyes diagnostics growth - AD HOC NEWS
Abbott completes acquisition of Exact Sciences - Abbott MediaRoom
Abbott Completes Exact Sciences Acquisition to Transform Global Cancer Diagnostics - geneonline.com
Abbott Expands Healthcare Ecosystem With Exact Sciences Acquisition - Built In Chicago
Exact Sciences Corp stock delisted from Nasdaq after $21 billion Abbott acquisition completion - AD HOC NEWS
Abbott finalizes purchase of Madison-based Exact Sciences - Spectrum News 1
0.41%
0.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):